Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZOSYN use-results survey in solid tumor patients with febrile neutropenia
jRCT1080223166Recruiting
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Apr 2016
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of piperacillin + tazobactam in febrile neutropenia (FN) and Non-hematologic malignancy, sponsored by Taiho Pharmaceutical Co., Ltd. Started Apr 2016; status: recruiting.
02
Drugs
piperacillin + tazobactam
03
Conditions
febrile neutropenia (FN)Non-hematologic malignancy
Beyond the preview
Go deeper on jRCT1080223166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080223166.